AION Labs is a first-of-its-kind alliance of global pharma and technology leaders and investors that have come together with one clear mission: to create and adopt gateway AI and computational technologies that will transform the process of drug discovery and development for the betterment of human health.
The alliance of four leading pharmaceutical companies – AstraZeneca, Merck, Pfizer, and Teva – and two leaders in the hi-tech and biotech investment sphere , respectively – Amazon Web Services Inc. and Israeli Biotech Fund (IBF) – who have come together with the aim of building groundbreaking AI and computational ventures that will leverage the cloud to transform how new therapies are discovered and developed.
They invite brilliant inventors, scientists and technologists to solve the biggest R&D challenges of today’s pharma with the support and guidance of years of accumulated know-how, data, and experience of our partners.
Backed by AION Lab’s partners’ wealth of knowledge and fresh multidisciplinary approach, they combine the ingenuity, agility and innovative instinct of Israel’s start-up ecosystem to create and develop strong companies with disruptive technology which will pave the way to the future of pharma.
